MedTrace Logo

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

NCT02915809 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 414

Last updated 2016-09-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate immunological efficacy and safety of GC3110B versus GCFLU Quadrivalent Inj. among healthy adults in 18 to 60 years of age.

Conditions

  • Influenza, Human

Interventions

BIOLOGICAL

GC3110B vaccine

0.5mL, Intramuscular

BIOLOGICAL

GCFLU Quadrivalent Inj. vaccine

0.5mL, Intramuscular

Sponsors & Collaborators

  • Green Cross Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2016-12-31
Completion
2017-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02915809 on ClinicalTrials.gov